Amgen Inc. v. Sanofi
| SANOFI, AVENTISUB LLC, fka Aventis Pharmaceuticals Inc., REGENERON PHARMACEUTICALS INC. and SANOFI-AVENTIS U.S. LLC |
| AMGEN MANUFACTURING LIMITED, AMGEN INC., AMGEN USA, INC. and AMGEN MANUFACTURING, LIMITED |
| 20-1074 |
| October 24, 2019 |
| U.S. Court of Appeals, Federal Circuit |
| Other |
Opinions
We have the following opinions for this case:
| Description |
|---|
 Amgen Inc. v. Sanofi, Aventisub LLC
|
| AMGEN INC. v. SANOFI |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 16, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 38 **TEXT ONLY** ORDER granting motion to extend time to file brief [ # 37 ] filed by Appellants Amgen USA, Inc., Amgen Inc., and Amgen Manufacturing, Limited. The opening brief is due 01/22/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [656657] [JAL] [Entered: 12/16/2019 09:16 AM] |
| Filing 37 MOTION of Appellants Amgen Inc., Amgen Manufacturing, Limited and Amgen USA, Inc. to extend the time to 01/22/2020 to file the Opening Brief. [Consent: unopposed]. Service: 12/13/2019 by email. [656581] [20-1074] [Jeffrey Lamken] [Entered: 12/13/2019 04:41 PM] |
| Filing 36 Notice to counsel for Appellants Amgen Inc., Amgen Manufacturing, Limited, and Amgen USA, Inc.: The record of this case indicates that the Corrected Entry of Appearance for C. Mead has not been filed. Service as of this date by the Clerk of Court. [655710] [JAL] [Entered: 12/11/2019 03:02 PM] |
| Filing 35 Official caption revised in response to Notice of Objection to the Official Caption [ # 5 ]. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by the Clerk of Court. [649867] [JAL] [Entered: 11/18/2019 09:05 AM] |
| Filing 34 NOTICE OF NON-COMPLIANCE: The submission of Appellants Amgen Inc., Amgen Manufacturing Limited, and Amgen USA, Inc., Entry of Appearance - C. Mead [ # 33 ], is not in compliance with the rules of this court (see attached). Compliant document is due on 11/21/2019. Service as of this date by the Clerk of Court. [649464] [JAL] [Entered: 11/14/2019 04:18 PM] |
| Filing 33 Entry of appearance for Christopher B. Mead as of counsel for. Service: 11/14/2019 by email. [649322] [20-1074] This document is non-compliant. See Doc No.[ # 34 ] [Christopher Mead] [Entered: 11/14/2019 01:43 PM] |
| Filing 32 Corrected Entry of appearance for William G. Gaede III as of counsel for Appellants Amgen Inc., Amgen Manufacturing Limited and Amgen USA, Inc.. Service: 11/14/2019 by clerk, email. [649316] [20-1074] [William Gaede] [Entered: 11/14/2019 01:32 PM] |
| Filing 31 Entry of appearance for Katherine Nicole Clouse as of counsel for Appellant Amgen Inc.. Service: 11/14/2019 by clerk, email. [649296] [20-1074] [Katherine Clouse] [Entered: 11/14/2019 01:09 PM] |
| Filing 30 Entry of appearance for Katherine Nicole Clouse as of counsel for Appellant Amgen Inc.. Service: 11/14/2019 by clerk, email. [649293] [20-1074] [Sarah Columbia] [Entered: 11/14/2019 01:00 PM] |
| Filing 29 Entry of appearance for Sarah Chapin Columbia as of counsel for Appellant Amgen Inc.. Service: 11/14/2019 by clerk, email. [649291] [20-1074] [Sarah Columbia] [Entered: 11/14/2019 12:58 PM] |
| Filing 28 NOTICE OF NON-COMPLIANCE: The submission of Amgen Inc., Amgen Manufacturing Limited, and Amgen USA, Inc., Entry of Appearance - W. Gaede III [ # 27 ], is not in compliance with the rules of this court (see attached). Compliant document due 11/21/2019. Service as of this date by the Clerk of Court. [649092]--[Edited 11/14/2019 by MJL to correct filed date] [JAL] [Entered: 11/13/2019 04:38 PM] |
| Filing 27 Entry of appearance for William G. Gaede, III as of counsel for Appellants Amgen Inc., Amgen Manufacturing Limited and Amgen USA, Inc. Service: 11/11/2019 by clerk, email. [648411] [20-1074] This document is non-compliant. See Doc No.[ # 28 ] [William Gaede] [Entered: 11/11/2019 12:11 PM] |
| Filing 26 Entry of appearance for Keith R. Hummel as of counsel for Appellants Amgen Inc., Amgen Manufacturing Limited and Amgen USA, Inc.. Service: 11/08/2019 by email. [648368] [20-1074] [Keith Hummel] [Entered: 11/08/2019 05:01 PM] |
| Filing 25 REMINDER : All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.3 to promptly submit an amended Entry of Appearance and/or update their contact information through the PACER Service Center as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [648262]--[Edited 11/08/2019 by JAL to amend docket text] [JAL] [Entered: 11/08/2019 03:15 PM] |
| Filing 24 Entry of appearance for Victoria Reines as of counsel for Appellees Sanofi, Sanofi-Aventis U.S. LLC, Aventisub LLC and Regeneron Pharmaceuticals Inc.. Service: 11/07/2019 by email. [647920] [20-1074] [Victoria Reines] [Entered: 11/07/2019 04:51 PM] |
| Filing 23 Entry of appearance for Deborah Fishman as of counsel for Appellees Sanofi, Sanofi-Aventis U.S. LLC, Aventisub LLC and Regeneron Pharmaceuticals Inc.. Service: 11/07/2019 by email. [647919] [20-1074] [Deborah Fishman] [Entered: 11/07/2019 04:47 PM] |
| Filing 22 Entry of appearance for David K. Barr as of counsel for Appellees Sanofi, Sanofi-Aventis U.S. LLC, Aventisub LLC and Regeneron Pharmaceuticals Inc.. Service: 11/07/2019 by email. [647913] [20-1074] [David Barr] [Entered: 11/07/2019 04:41 PM] |
| Filing 21 Entry of appearance for Daniel L. Reisner as of counsel for Appellees Sanofi, Sanofi-Aventis U.S. LLC, Aventisub LLC and Regeneron Pharmaceuticals Inc.. Service: 11/07/2019 by email. [647907] [20-1074] [Daniel Reisner] [Entered: 11/07/2019 04:37 PM] |
| Filing 20 Entry of appearance for Anne Pearlman as of counsel for Appellees Sanofi, Sanofi-Aventis U.S. LLC, Aventisub LLC and Regeneron Pharmaceuticals Inc.. Service: 11/07/2019 by email. [647903] [20-1074] [Anne Pearlman] [Entered: 11/07/2019 04:32 PM] |
| Filing 19 Entry of appearance for Stephanie Donahue as of counsel for Appellees Sanofi, Sanofi-Aventis U.S. LLC and Aventisub LLC. Service: 11/07/2019 by email. [647898] [20-1074] [Anne Pearlman] [Entered: 11/07/2019 04:28 PM] |
| Filing 18 Entry of appearance for Lynda Q. Nguyen as of counsel for Appellee Regeneron Pharmaceuticals Inc.. Service: 11/07/2019 by email. [647893] [20-1074] [Anne Pearlman] [Entered: 11/07/2019 04:25 PM] |
| Filing 17 Entry of appearance for James L. Higgins as of counsel for Appellants Amgen Inc., Amgen Manufacturing Limited and Amgen USA, Inc.. Service: 11/07/2019 by email. [647889] [20-1074] [James Higgins] [Entered: 11/07/2019 04:23 PM] |
| Filing 16 Entry of appearance for Larry Coury as of counsel for Appellee Regeneron Pharmaceuticals Inc.. Service: 11/07/2019 by email. [647886] [20-1074] [Anne Pearlman] [Entered: 11/07/2019 04:22 PM] |
| Filing 15 Entry of appearance for Melanie K. Sharp as of counsel for Appellants Amgen Inc., Amgen Manufacturing Limited and Amgen USA, Inc.. Service: 11/07/2019 by email. [647876] [20-1074] [Melanie Sharp] [Entered: 11/07/2019 04:14 PM] |
| Filing 14 Entry of appearance for Matthew W. Wolf as principal counsel for Appellees Sanofi, Sanofi-Aventis U.S. LLC, Aventisub LLC and Regeneron Pharmaceuticals Inc.. Service: 11/07/2019 by email. [647871] [20-1074] [Matthew Wolf] [Entered: 11/07/2019 04:05 PM] |
| Filing 13 Certificate of Interest for Appellees Aventisub LLC, Regeneron Pharmaceuticals Inc., Sanofi and Sanofi-Aventis U.S. LLC. Service: 11/07/2019 by email. [647840] [20-1074] [Calvin Shank] [Entered: 11/07/2019 03:19 PM] |
| Filing 12 Docketing Statement for the Appellees Aventisub LLC, Regeneron Pharmaceuticals Inc., Sanofi and Sanofi-Aventis U.S. LLC. Service: 11/07/2019 by email. [647838] [20-1074] [Calvin Shank] [Entered: 11/07/2019 03:18 PM] |
| Filing 11 Entry of appearance for C. Alex Shank as of counsel for Appellees Aventisub LLC, Regeneron Pharmaceuticals Inc., Sanofi and Sanofi-Aventis U.S. LLC. Service: 11/07/2019 by email. [647836] [20-1074] [Calvin Shank] [Entered: 11/07/2019 03:16 PM] |
| Filing 10 Entry of appearance for Nathan S. Mammen as of counsel for Appellees Aventisub LLC, Regeneron Pharmaceuticals Inc., Sanofi and Sanofi-Aventis U.S. LLC. Service: 11/07/2019 by email. [647834] [20-1074] [Calvin Shank] [Entered: 11/07/2019 03:15 PM] |
| Filing 9 Entry of appearance for George W. Hicks as of counsel for Appellees Aventisub LLC, Regeneron Pharmaceuticals Inc., Sanofi and Sanofi-Aventis U.S. LLC. Service: 11/07/2019 by email. [647833] [20-1074] [Calvin Shank] [Entered: 11/07/2019 03:14 PM] |
| Filing 8 Entry of appearance for Sara E. Margolis as of counsel for Appellants Amgen Inc., Amgen Manufacturing Limited and Amgen USA, Inc.. Service: 11/07/2019 by email. [647797] [20-1074] [Sara Margolis] [Entered: 11/07/2019 02:19 PM] |
| Filing 7 Entry of appearance for Sarah J. Newman as of counsel for Appellants Amgen Inc., Amgen Manufacturing Limited and Amgen USA, Inc.. Service: 11/07/2019 by email. [647791] [20-1074] [Sarah Newman] [Entered: 11/07/2019 02:14 PM] |
| Filing 6 Entry of appearance for Michael G. Pattillo, Jr. as of counsel for Appellants Amgen Inc., Amgen Manufacturing Limited and Amgen USA, Inc.. Service: 11/07/2019 by email. [647789] [20-1074] [Michael Pattillo] [Entered: 11/07/2019 02:10 PM] |
| Filing 5 Objection to the official caption pursuant to Rule 12 Practice Note by Appellants Amgen Inc., Amgen Manufacturing Limited and Amgen USA, Inc.. Service: 11/07/2019 by email. [647785] [20-1074] [Jeffrey Lamken] [Entered: 11/07/2019 02:08 PM] |
| Filing 4 Docketing Statement for the Appellants Amgen Inc., Amgen Manufacturing Limited and Amgen USA, Inc.. Service: 11/07/2019 by email. [647781] [20-1074] [Jeffrey Lamken] [Entered: 11/07/2019 02:06 PM] |
| Filing 3 Certificate of Interest for Appellants Amgen Inc., Amgen Manufacturing Limited and Amgen USA, Inc.. Service: 11/07/2019 by email. [647779] [20-1074] [Jeffrey Lamken] [Entered: 11/07/2019 02:05 PM] |
| Filing 2 Entry of appearance for Jeffrey A. Lamken as principal counsel for Appellants Amgen Inc., Amgen Manufacturing Limited and Amgen USA, Inc.. Service: 11/07/2019 by email. [647778] [20-1074] [Jeffrey Lamken] [Entered: 11/07/2019 02:03 PM] |
| Filing 1 Appeal docketed. Received: 10/23/2019. [644354] Entry of Appearance is due 11/07/2019. Certificate of Interest is due on 11/07/2019. Docketing Statement is due 11/07/2019. Appellant's brief is due 12/23/2019. [JAL] [Entered: 10/24/2019 10:10 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
